Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetic Models: Overview

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Risk factors for atrial fibrillation in Ibadan, Nigeria: A case-controlled study.

Journal of the National Medical Association·2026

Same author

Prevalence and inequalities of missed opportunities for intermittent preventive therapy (IPTp) of malaria among pregnant women: an analysis of 2018 Nigeria DHS.

Malaria journal·2026

Same author

Educational attainment is associated with reduced functional decline in Puerto Ricans with elevated pTau181.

Journal of Alzheimer's disease : JAD·2026

Same author

Community voices: Exploring beliefs, attitudes, practices and recommendations for improving stroke prevention and stroke care in rural and urban communities in Nigeria.

PloS one·2026

Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Same journal

Explainable machine learning-based preliminary screening for viral encephalitis by blood routine analysis.

Frontiers in neurology·2026

Same journal

Global landscape of registered clinical trials of stem cell therapy for spinal cord injury: a cross-sectional analysis.

Frontiers in neurology·2026

Same journal

Experimental verification and PK/PD modeling of selective drug absorption via acupoint administration in rabbit model of rheumatoid arthritis.

Frontiers in neurology·2026

Same journal

Plasma metabolomic signatures of the no-reflow phenomenon in stroke patients following thrombectomy.

Frontiers in neurology·2026

Same journal

Parametric color-coding-derived microvascular transit time may predict infarction and reveals microcirculatory benefits of Tenecteplase in acute ischemic stroke.

Frontiers in neurology·2026

Same journal

The application of fNIRS-sEMG in the study of muscle-brain coupling.

Frontiers in neurology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 7, 2025

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

Predictive model for aminoglycoside induced ototoxicity.

Adebolajo A Adeyemo^1,2, Josephine Adeolu¹, Joshua O Akinyemi³

¹Institute of Child Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Frontiers in Neurology

|November 18, 2024

Summary

This summary is machine-generated.

Aminoglycoside ototoxicity, a significant risk of hearing loss, can now be predicted in the general population. A new model identifies age, cumulative dosage, and baseline hearing as key predictors, improving clinical care.

Keywords:

aminoglycosides model validation ototoxicity predictive model tuberculosis

More Related Videos

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Published on: January 9, 2019

Related Experiment Videos

Last Updated: Jun 7, 2025

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice

Published on: January 9, 2019

Area of Science:

Pharmacology and Toxicology
Otolaryngology
Biostatistics

Background:

Aminoglycoside antibiotics are associated with irreversible hearing loss, a critical adverse effect.
Accurate prediction of aminoglycoside-induced ototoxicity remains a significant clinical challenge.
This study aimed to develop a predictive model for aminoglycoside ototoxicity applicable to the general population.

Purpose of the Study:

To develop and validate a predictive model for aminoglycoside ototoxicity.
To identify key clinical and audiological predictors of ototoxicity in patients receiving Streptomycin-based anti-tuberculosis therapy.

Main Methods:

A prospective cohort of 153 adults treated with Streptomycin for non-drug-resistant tuberculosis was studied.
High-frequency pure-tone audiometry was performed regularly to assess hearing changes.
Logistic regression was used to develop a prediction model incorporating variables such as age, cumulative dosage, and baseline pure tone average (PTA).

Main Results:

Ototoxicity was observed in 35% of the participants.
Age, cumulative Streptomycin dosage, and baseline PTA were identified as significant predictors of ototoxicity.
The developed model demonstrated good discriminatory ability with an area under the receiver operating characteristic curve of 0.84 for training and 0.79 for validation.

Conclusions:

A validated prediction model for aminoglycoside ototoxicity has been developed.
This model, utilizing age, cumulative dosage, and baseline PTA, can aid in predicting ototoxicity risk in the general population.
The findings can improve clinical management and patient counseling regarding aminoglycoside therapy.